* iRhythm Technologies Inc IRTC.OQ reported a quarterly
adjusted
loss of 89 cents per share for the quarter ended in September,
lower than the same quarter last year, when the company reported
EPS of -63 cents. The mean expectation of twelve analysts for
the quarter was for a loss of 66 cents per share. Wall Street
expected results to range from -75 cents to -55 cents per share.
* Revenue rose 20% to $124.60 million from a year ago;
analysts
expected $122.57 million.
* iRhythm Technologies Inc's reported EPS for the quarter
was a
loss of 89 cents.
* The company reported a quarterly loss of $27.12 million.
* iRhythm Technologies Inc shares had fallen by 16.3% this
quarter and lost 15.7% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 6% in
the last three months.
* In the last 30 days, there have been no negative revisions
of
earnings estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"
Wall Street's median 12-month price target for iRhythm
Technologies Inc is $132.00
This summary was machine generated from LSEG data November 2 at
09:59 p.m. UTC. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2023 -0.66 -0.89 Missed
Jun. 30 2023 -0.78 -0.61 Beat
Mar. 31 2023 -0.90 -1.10 Missed
Dec. 31 2022 -0.62 -0.67 Missed